152 related articles for article (PubMed ID: 26284132)
21. The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis.
Jung SP; Kim S; Nam SJ; Kim I; Bae JW
J Breast Cancer; 2013 Mar; 16(1):16-22. PubMed ID: 23593077
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.
Krasteva ME; Bozhanov SS; Antov GG; Gospodinova ZI; Angelov SG
Neoplasma; 2012; 59(1):85-91. PubMed ID: 22103901
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
[TBL] [Abstract][Full Text] [Related]
24. BRCA2 carriers with male breast cancer show elevated tumour methylation.
Deb S; Gorringe KL; Pang JB; Byrne DJ; Takano EA; ; Dobrovic A; Fox SB
BMC Cancer; 2017 Sep; 17(1):641. PubMed ID: 28893223
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
26. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
29. Gene promoter hypermethylation in tumors and plasma of breast cancer patients.
Bae YK; Shim YR; Choi JH; Kim MJ; Gabrielson E; Lee SJ; Hwang TY; Shin SO
Cancer Res Treat; 2005 Aug; 37(4):233-40. PubMed ID: 19956520
[TBL] [Abstract][Full Text] [Related]
30. Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients.
Shukla S; Mirza S; Sharma G; Parshad R; Gupta SD; Ralhan R
Epigenetics; 2006; 1(2):88-93. PubMed ID: 17998817
[TBL] [Abstract][Full Text] [Related]
31. White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.
Lønning PE; Berge EO; Bjørnslett M; Minsaas L; Chrisanthar R; Høberg-Vetti H; Dulary C; Busato F; Bjørneklett S; Eriksen C; Kopperud R; Axcrona U; Davidson B; Bjørge L; Evans G; Howell A; Salvesen HB; Janszky I; Hveem K; Romundstad PR; Vatten LJ; Tost J; Dørum A; Knappskog S
Ann Intern Med; 2018 Mar; 168(5):326-334. PubMed ID: 29335712
[TBL] [Abstract][Full Text] [Related]
32.
Bai X; Fu Y; Xue H; Guo K; Song Z; Yu Z; Jia T; Yan Y; Zhao L; Mi X; Wang E; Zheng Z; Zhao H; Yao W; Wei M
Oncol Lett; 2014 Apr; 7(4):1088-1096. PubMed ID: 24944674
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients.
Jing F; Zhang J; Tao J; Zhou Y; Jun L; Tang X; Wang Y; Hai H
Onkologie; 2007 Feb; 30(1-2):14-9. PubMed ID: 17264521
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.
Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM
Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542
[TBL] [Abstract][Full Text] [Related]
36. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
37. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
38. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Gupta S; Jaworska-Bieniek K; Narod SA; Lubinski J; Wojdacz TK; Jakubowska A
Breast Cancer Res Treat; 2014 Dec; 148(3):615-22. PubMed ID: 25376744
[TBL] [Abstract][Full Text] [Related]
39. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
[TBL] [Abstract][Full Text] [Related]
40.
Jacot W; Lopez-Crapez E; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Ho-Pun-Cheung A; Chartron E; Theillet C; Lemoine A; Saffroy R; Lamy PJ; Guiu S
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]